Consainsights logo
Reports > Life Sciences > Carotid Artery Stents Market Report

Carotid Artery Stents Market Size, Share, Industry Trends and Forecast to 2033

This report provides an in-depth analysis of the Carotid Artery Stents market, covering market size, trends, and forecasts from 2023 to 2033. Insights are provided on segmentation, regional performance, technology advancements, and key industry players.

Metric Value
Study Period 2023 - 2033
2023 Market Size $800.00 Million
CAGR (2023-2033) 5.6%
2033 Market Size $1397.07 Million
Top Companies Medtronic, Boston Scientific, Abbott Laboratories, Johns Hopkins Health System
Last Modified Date 15 Nov 2024

Carotid Artery Stents Market Report (2023 - 2033)

Carotid Artery Stents Market Overview

The Carotid Artery Stents industry is a critical component of the medical devices sector, focusing on improving patient outcomes concerning carotid artery diseases. The industry comprises various stakeholders, including manufacturers, hospitals, and clinics. Innovation is at the forefront, with new materials and technology improving stent functionality and patient safety. However, market challenges such as regulatory hurdles and cost considerations for healthcare systems require strategic navigation by industry players. Furthermore, the competitive landscape is increasingly dominated by key players investing in research and development to introduce next-generation stents.

What is the Market Size & CAGR of the Carotid Artery Stents market in 2023?

The Carotid Artery Stents market is projected to reach approximately $1,160.00 million in 2023. The market expects robust growth with a CAGR of around 6.5% from 2023 to 2033. Factors such as rising obesity rates, sedentary lifestyles, and advances in minimally invasive surgical techniques will foster market growth. The introduction of bioresorbable stents and advancements in imaging technologies further enhance treatment efficacy, driving market penetration.

Carotid Artery Stents Industry Analysis

The Carotid Artery Stents industry is a critical component of the medical devices sector, focusing on improving patient outcomes concerning carotid artery diseases. The industry comprises various stakeholders, including manufacturers, hospitals, and clinics. Innovation is at the forefront, with new materials and technology improving stent functionality and patient safety. However, market challenges such as regulatory hurdles and cost considerations for healthcare systems require strategic navigation by industry players. Furthermore, the competitive landscape is increasingly dominated by key players investing in research and development to introduce next-generation stents.

Carotid Artery Stents Market Segmentation and Scope

The market for Carotid Artery Stents can be segmented based on product type, material, application area, and end-user. Product types include self-expanding and balloon-expandable stents. Material segmentation considers metal, polymer, and composite stents. The application area segmentation covers ischemic stroke prevention and transient ischemic attack management. End-users include hospitals, ambulatory surgical centers, and specialty clinics. Each segment contributes uniquely to the market, with certain areas experiencing higher growth rates based on demographic and technological influences.

Request a custom research report for industry.

Carotid Artery Stents Market Analysis Report by Region

Europe Carotid Artery Stents Market Report:

In Europe, the Carotid Artery Stents market is set to grow from $254.96 million in 2023 to approximately $445.25 million by 2033. Regulatory support for innovative medical devices and increasing healthcare spending drive this expansion.

Asia Pacific Carotid Artery Stents Market Report:

The Asia Pacific region is witnessing significant growth in the Carotid Artery Stents market with a forecast size of $234.43 million by 2033, up from $134.24 million in 2023. The increasing prevalence of cardiovascular diseases and rising investments in healthcare infrastructure are major growth drivers.

North America Carotid Artery Stents Market Report:

North America holds a significant market share for Carotid Artery Stents, valued at $293.60 million in 2023 and projected to reach $512.72 million by 2033. High rates of carotid artery disease and advanced healthcare technologies propel market growth.

South America Carotid Artery Stents Market Report:

The South American market for Carotid Artery Stents is projected to increase from $46.32 million in 2023 to $80.89 million in 2033. Growing healthcare awareness and improving medical facilities contribute to the region's market expansion.

Middle East & Africa Carotid Artery Stents Market Report:

The Middle East and Africa market for Carotid Artery Stents is estimated to grow from $70.88 million in 2023 to $123.78 million by 2033. Growth is supported by rising healthcare investment and infrastructure development aimed at improving cardiovascular health outcomes.

Request a custom research report for industry.

Carotid Artery Stents Market Analysis By Product Type

Global Carotid Artery Stents Market, By Product Type Market Analysis (2023 - 2033)

The product type segmentation reveals a strong preference for self-expanding stents, which dominate the market with a share of 81.02% in 2023. The market size for self-expanding stents is expected to reach $1,131.91 million by 2033. Balloon-expandable stents, while smaller in share (18.98%), show promising growth potential attributed to their use in specific applications.

Carotid Artery Stents Market Analysis By Material

Global Carotid Artery Stents Market, By Material Market Analysis (2023 - 2033)

Among the material types, metal stents continue to lead the market, capturing 65.5% share in 2023, with market projections suggesting growth to $915.08 million by 2033. Polymer and composite stents follow, making notable contributions with sizes increasing to $293.52 million and $188.46 million respectively.

Carotid Artery Stents Market Analysis By Application Area

Global Carotid Artery Stents Market, By Application Area Market Analysis (2023 - 2033)

In application segments, ischemic stroke prevention represents the largest market share of 65.5% in 2023 and is projected for steady growth due to increasing incidence rates. For transient ischemic attacks, the market is also set to expand from $168.08 million to $293.52 million by 2033.

Carotid Artery Stents Market Analysis By End User

Global Carotid Artery Stents Market, By End-User Market Analysis (2023 - 2033)

Hospitals account for the largest share of the Carotid Artery Stents market at 65.5%, reflecting the preference for advanced treatment options in surgical settings. Ambulatory surgical centers are gradually increasing their share, expected to grow to $293.52 million by 2033 due to rising patient volume and lower-cost procedures.

Request a custom research report for industry.

Global Market Leaders and Top Companies in Carotid Artery Stents Industry

Medtronic:

A leader in medical technology, Medtronic designs and manufactures stents with advanced features enhancing patient outcomes.

Boston Scientific:

Specializing in the development of stenting solutions, Boston Scientific is known for innovation in minimally invasive medical devices.

Abbott Laboratories:

Abbott offers a range of carotid stents, focusing on quality and effectiveness to meet the needs of healthcare providers and patients.

Johns Hopkins Health System:

Involved in innovative research in carotid artery interventions, Johns Hopkins contributes significantly to advancing stent technologies.

We're grateful to work with incredible clients.

Datasite
Agilent
Asten Johnson
Bio-Rad
Carl Zeiss
Dywidag
Illumina
LEK Consulting
Shell

Related Industries

    FAQs